Drug Therapy
Showing 9926 - 9950 of >10,000
Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Boston (Amlodipine)
Recruiting
- Primary Aldosteronism
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
-
Boston, MassachusettsAnand Vaidya
Nov 26, 2021
Alopecia, Androgenetic Trial (Clascoterone 5% solution, Vehicle solution)
Not yet recruiting
- Alopecia, Androgenetic
- Clascoterone 5% solution
- Vehicle solution
- (no location specified)
Jun 15, 2023
Peripheral Neuropathy Due to Chemo Trial in Cairo (Losartan)
Recruiting
- Peripheral Neuropathy Due to Chemotherapy
-
Cairo, EgyptBreast Cancer Comprehensive Center of the National Cancer Instit
Nov 26, 2023
Peripheral T-cell Lymphoma Trial (Linperlisib in combination with CHOP)
Not yet recruiting
- Peripheral T-cell Lymphoma
- Linperlisib in combination with CHOP
- (no location specified)
Jul 10, 2023
Epileptic Seizures Related to Drugs Trial in Xi'an (minocycline)
Enrolling by invitation
- Epileptic Seizures Related to Drugs
-
Xi'an, Shaanxi, ChinaXijingHospital
Jul 21, 2023
Spasticity in Participants With Multiple Sclerosis Trial in Czechia, Poland (Nabiximols, Placebo)
Completed
- Spasticity in Participants With Multiple Sclerosis
- Nabiximols
- Placebo
-
Choceň, Czechia
- +15 more
Jun 29, 2022
NSCLC Trial in Worldwide (Durvalumab, Placebo, Osimertinib (single-arm, open-label))
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Durvalumab
- +2 more
-
Tuscaloosa, Alabama
- +260 more
Dec 16, 2022
Psoriatic Arthritis Trial in Worldwide (Adalimumab, Upadacitinib, Placebo to Upadacitinib)
Active, not recruiting
- Psoriatic Arthritis
- Adalimumab
- +3 more
-
Huntsville, Alabama
- +344 more
Dec 27, 2021
Methadone-Induced QT Interval Prolongation inNarcotic Treatment
Completed
- QT Interval Prolongation
- AliveCor handheld mobile ECG
-
Indianapolis, IndianaEskenazi Health
Jul 6, 2021
Prostatic Hyperplasia, Prostate Hyperplasia, Prostatic Hypertrophy Trial in Seoul (alpha-blocker or 5-ARI withdrawal,
Recruiting
- Prostatic Hyperplasia
- +2 more
- alpha-blocker or 5-ARI withdrawal
- Maintenance of alpha-blocker and 5-ARI
-
Seoul, Korea, Republic ofGangnam Severance Hospital, Yonsei University College of Medicin
Aug 21, 2021
Swimming Induced Pulmonary Edema (SIPE), Pulmonary Edema, Lung Diseases Trial in Falun (Oxygen + continuous positive airway
Recruiting
- Swimming Induced Pulmonary Edema (SIPE)
- +2 more
- Oxygen + continuous positive airway pressure (CPAP)
- Oxygen
-
Falun, SwedenCenter of Clinical Research Dalarna
Jul 2, 2022
Systemic Sclerosis Trial in Palermo (combination ultrasound therapy and manual therapy, manual therapy)
Completed
- Systemic Sclerosis
- combination ultrasound therapy and manual therapy
- manual therapy
-
Palermo, ItalyFunctional Recovery and Rehabilitation Unit of the A.O.U.P. Paol
Jun 18, 2023
Rheumatoid Arthritis Trial in Ubbergen, Amsterdam (Adalimumab trough concentration, Usual care)
Recruiting
- Rheumatoid Arthritis
- Adalimumab trough concentration
- Usual care
-
Ubbergen, Gelderland, Netherlands
- +1 more
Jun 8, 2021
Renal Transplantation, Mesenchymal Stem Cells Trial in Houston (Mesenchymal Stromal Stem Cells (MSCs) Infusion, Normal Saline
Recruiting
- Renal Transplantation
- Mesenchymal Stem Cells
- Mesenchymal Stromal Stem Cells (MSCs) Infusion
- Normal Saline (Placebo) Infusion
-
Houston, TexasHouston Methodist Hospital System
Mar 8, 2022
Locally Advanced Rectal Adenocarcinoma Trial in United States (APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and
Recruiting
- Locally Advanced Rectal Adenocarcinoma
- APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days
- mFOLFOX and Radiation Therapy 5Gy x 5 days
-
Winston-Salem, North Carolina
- +2 more
Sep 14, 2021
Migraine Disorders, Headache Disorders Trial in Memphis (SPN-538, Placebo)
Recruiting
- Migraine Disorders
- Headache Disorders
- SPN-538
- Placebo
-
Memphis, TennesseeCNS Healthcare
Nov 29, 2021
Efficiency of Caplacizumab in the Treatment of aTTP
Recruiting
- Acquired Thrombotic Thrombocytopenic Purpura
-
Cologne, GermanyUniversity Hospital of Cologne
Dec 28, 2021
Immune Checkpoint Inhibitor Therapy on Type 2 Inflammation
Completed
- Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies
- Anti-PD-1 or anti-PD-L1
-
Montpellier, FranceUH Montpellier
Dec 22, 2021
Breast Cancer, HER2-negative Breast Cancer Trial in Canada, United States (Paclitaxel, Eribulin, Doxorubicin)
Completed
- Breast Cancer
- HER2-negative Breast Cancer
- Paclitaxel
- +3 more
-
Denver, Colorado
- +19 more
Oct 4, 2021
Metastatic Urothelial Cancer Trial in France, United States (Sacituzumab Govitecan-hziy, Pembrolizumab, Cisplatin)
Recruiting
- Metastatic Urothelial Cancer
- Sacituzumab Govitecan-hziy
- +7 more
-
Tucson, Arizona
- +44 more
Jan 9, 2023
Patients After PCI:a Multi-center Study
Recruiting
- hsCRP
-
Wuhan, Hubei, ChinaDepartment of Cardiology, Union Hospital, Tongji Medical College
Jan 1, 2023